Literature DB >> 7417491

Collagen biosynthesis by human skin fibroblasts. II. Isolation and further characterization of type I and type III procollagens synthesized in culture.

J Uitto, B A Booth, K L Polak.   

Abstract

Human skin fibroblasts in culture have previously been shown to synthesize genetically distinct procollagens type I and type III. In the present study, cultured human skin fibroblasts were incubated under conditions optimized for synthesis of these procollagens in medium containing [3H]proline. The newly synthesized type I and type III 3H-labeled procollagens in the culture medium were then isolated as native proteins by DEAE-cellulose chromatography, or by gel filtration and SDS-polyacrylamide slab gel electrophoresis under denaturing conditons after limited pepsin proteolysis. The chromatographic procedures were optimized to yield reliable and reporducible results with good recoveries. The isolated procollagens were identified by cyanogen bromide peptide mapping and characterized by cleavage with highly purified collagenase synthesized by human skin fibroblasts. Assay of the relative synthesis of type I/III procollagens by normal human skin fibroblasts using DEAE-cellulose chromatography indicated that 80% of the procollagen in the medium was type I while the remaining 20% consisted of type III. When the ratio of newly-synthesized type I/III collagens was estimated by gel filtration or using SDS-polyacrylamide slab gel electrophoresis after limited pepsin proteolysis, relatively fewer type III collagen alpha-chains were recovered. This observation suggests that some of the type of the type III collagen molecules are in a conformation which is less resistant to digestion by pepsin than the triple-helix of type I procollagen. The coefficient of variation for the relative synthesis of type I and type III procollagens by control cultures was relatively small (16%), indicating that the phenotypic expression of type I and type III procollagen genes, under optimized culture conditions, is under a relatively tight control. The results further suggest that the optimized methodology developed for assay of the relative synthesis of type I and type III procollagens and collagens by cultured human skin fibroblasts can be utilized in studies on collagen aberrations in acquired and inherited diseases of connective tissue.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417491     DOI: 10.1016/0005-2795(80)90095-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. Relevance to imparied wound healing.

Authors:  T Sasaki; K C Holeyfield; J Uitto
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Purification of human procollagen type III N-proteinase from placenta and preparation of antiserum.

Authors:  R Halila; L Peltonen
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

Review 3.  Learning from regeneration research organisms: The circuitous road to scar free wound healing.

Authors:  Jami R Erickson; Karen Echeverri
Journal:  Dev Biol       Date:  2017-11-24       Impact factor: 3.582

4.  Collagen synthesis by human bone marrow fibroblasts.

Authors:  M Fernández; J J Minguell
Journal:  Experientia       Date:  1987-12-01

5.  Interaction of procollagen I and other collagens with colligin.

Authors:  N Jain; A Brickenden; I Lorimer; E H Ball; B D Sanwal
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts.

Authors:  A Ghahary; Y J Shen; B Nedelec; P G Scott; E E Tredget
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

7.  A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis.

Authors:  J A McDonald; T J Broekelmann; M L Matheke; E Crouch; M Koo; C Kuhn
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

8.  Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.

Authors:  R Tenni; G Cetta; K Dyne; A Rossi; D Quacci; L Lenzi; A A Castellani
Journal:  Hum Genet       Date:  1988-07       Impact factor: 4.132

9.  Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: Finding novel anti-fibrotic therapies.

Authors:  Zhenping Chen; Jianhua Gu; Amina El Ayadi; Andres F Oberhauser; Jia Zhou; Linda E Sousse; Celeste C Finnerty; David N Herndon; Paul J Boor
Journal:  Toxicol Appl Pharmacol       Date:  2018-09-22       Impact factor: 4.219

10.  Decreased procollagen production in cultured fibroblasts from patients with Lowe's syndrome.

Authors:  M J Palmieri; J O'Hara; B States; S Segal
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.